Osteotech's Plexur(R) Technology to Be Used in Craniofacial Reconstruction Program Funded by the Armed Forces Institute of Regenerativ... (craniofacial region and elsewhere in the...)

HOME >> BIOLOGY >> TECHNOLOGY

Osteotech's Plexur(R) Technology to Be Used in Craniofacial Reconstruction Program Funded by the Armed Forces Institute of Regenerative Medicine

Date:5/2/2008

craniofacial region and elsewhere in the body to treat damage from these very difficult injuries."

Osteotech previously obtained a license from Carnegie Mellon University for the biodegradable polyurethane that is to be used in this program. This biodegradable polyurethane, in combination with Osteotech's Plexur(R) Technology, has been licensed to Vanderbilt University for research purposes. The collaborative research efforts are directed in part, towards developing a biocomposite that has unique characteristics, including high compressive, torsional or bending strength. Osteotech has the rights to any product developed within its current Plexur(R) intellectual property estate and a non-exclusive right to any technology improvements.

The Plexur(R) Technology uses bone tissue for procedure-specific surgical applications in combination with a wide variety of polymers. On a world-wide basis, Osteotech controls over 33 patents and over 65 pending patent applications covering this technology for human and xenograft bone tissue. For more information about the Plexur(R) Technology or Osteotech's Plexur P(TM) or Plexur M(TM) Biocomposites, please go to the Osteotech website at http://www.osteotech.com.

The New Jersey Center for Biomaterials is an academic research center at Rutgers, The State University of New Jersey. The center links research universities nationwide with industry and government to develop advanced materials for tissue repair and replacement, and drug delivery systems. Technology invented at the center is currently being licensed by three companies for the development of cardiovascular, ophthalmic and surgical implants. For further information regarding the New Jersey Center for Biomaterials, please visit http://www.njbiomaterials.com.

Osteotech, Inc., headquartered in Eatontown, New Jersey, is a global leader in provid
'/>"/>

0

GOOD

Page: 1 2 3
Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. Novel Technology Breaks Through Cancer Pain
3. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
4. Advanced Cell Technology Announces Proposed Financing
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
7. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
8. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
9. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
10. China Technology Announces New Chief Financial Officer
11. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan

Post Your Comments:

Osteotech's Plexur(R) Technology to Be Used in Craniofacial Reconstruction Program Funded by the Armed Forces Institute of Regenerativ...(craniofacial region and elsewhere in the...)